Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...
Схожі ресурси
Схожі ресурси
-
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
за авторством: Claudia Crimi, та інші
Опубліковано: (2023-11-01) -
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
за авторством: Carla Rognoni, та інші
Опубліковано: (2023-06-01) -
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
за авторством: Paolo Solidoro, та інші
Опубліковано: (2022-01-01) -
Critical evaluation of asthma biomarkers in clinical practice
за авторством: Giuseppe Guida, та інші
Опубліковано: (2022-10-01) -
Nasal polyps impact in severe asthma patients: evidences from the SANI
за авторством: Giorgio Walter Canonica, та інші
Опубліковано: (2020-08-01)